Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001711279-24-000040
Filing Date
2024-08-05
Accepted
2024-08-05 08:08:09
Documents
66
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q krys-20240630.htm   iXBRL 10-Q 1412058
2 EX-10.1 executivechangeinctrlsever.htm EX-10.1 292702
3 EX-10.2 firstamendmentto2017iposto.htm EX-10.2 22902
4 EX-31.1 krys-20240630ex311june.htm EX-31.1 10688
5 EX-31.2 krys-20240630ex312june.htm EX-31.2 10651
6 EX-32.1 krys-20240630ex321june.htm EX-32.1 11160
  Complete submission text file 0001711279-24-000040.txt   6610790

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT krys-20240630.xsd EX-101.SCH 36646
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT krys-20240630_cal.xml EX-101.CAL 66252
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT krys-20240630_def.xml EX-101.DEF 159808
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT krys-20240630_lab.xml EX-101.LAB 540714
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT krys-20240630_pre.xml EX-101.PRE 350359
69 EXTRACTED XBRL INSTANCE DOCUMENT krys-20240630_htm.xml XML 855862
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

EIN.: 821080209 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38210 | Film No.: 241173169
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)